What is BioVie Inc Annual Net Profit?

BioVie Inc Annual Net Profit rose 36.09% in the last year to $32.12 M. Its sector's average net profit growth for the last fiscal year was -32.43%.

What is BioVie Inc Price to Earning Ratio?

BioVie Inc Price to Earning Ratio is -0.85, which is negative.

What is BioVie Inc Stock Price?

BioVie Inc Stock Price rose 93.1% and outperformed its sector by 84.03% in the past year.

What is BioVie Inc Quarterly Net profit?

BioVie Inc Quarterly Net profit rose 15.34% YoY to $7.11 M. Its sector's average net profit growth YoY for the quarter was -47.3%.

What is BioVie Inc Debt to Equity Ratio?

BioVie Inc Debt to Equity Ratio of 0.39 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is BioVie Inc Return on Equity(ROE)?

BioVie Inc Return on Equity(ROE) for the last financial year was -214.01%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is BioVie Inc Mutual Fund Holding?

BioVie Inc Mutual Fund Holding increased by 2.57% in the last quarter to 4.61.

What is BioVie Inc Promoter Share Holding?

BioVie Inc Promoter Share Holding stayed the same in the most recent quarter at 7.89%.

What is BioVie Inc Interest Coverage Ratio?

BioVie Inc Interest Coverage Ratio is -10.1, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is BioVie Inc Institutional Holding?

BioVie Inc Institutional Holding increased by 2.86% in the last quarter to 9.68.

How is the BioVie Inc today?

The BioVie Inc today is trading in the down by -2.61% at 1.12.

How has BioVie Inc performed historically?

The BioVie Inc is currently trading down -2.61% on an intraday basis in the past week the index rose 3.70%. The index has been down -41.05% in the past quarter and rose 93.10% in the past year. You can view this in the overview section.

BioVie Inc XNAS: BIVI

BioVie Inc Live Share Price Today, Share Analysis and Chart

Name: BioVie Inc: Is Infosys Ltd. worth buying?
Item: BioVie Inc
Rating: 1.01175
Author: Trendlyne DVM scores

Download real time

1.12 -0.03 (-2.61%)

85.07% Fall from 52W High

291.8K XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

BioVie Inc Key Metrics

My Metrics

Default

Market Capitalization Low in industry Unavailable in chosen country	20.7
PE TTM Negative PE TTM Unavailable in chosen country	-0.9
Price to Book Below industry Median Unavailable in chosen country	0.9
Institutional holding current Qtr % Low in industry Unavailable in chosen country	9.7
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	15.3
Net Profit TTM Growth % High in industry Unavailable in chosen country	43.9
Piotroski Score Below industry Median Unavailable in chosen country	2
Rel Perf vs Sector quarter% Unavailable in chosen country	-49.7
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-214
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-109.5

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

11.5 / 100

Technically Bearish

29.0 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

BioVie Inc Stock Price Analysis

Day Price Range -2.6% 1 Day return Unavailable in chosen country	1.1 (LTP) 1.11.2 LowHigh
Week Price Range 3.7% 1 Week return Unavailable in chosen country	1.1 (LTP) 11.2 LowHigh
Month Price Range -24.3% 1 Month return Unavailable in chosen country	1.1 (LTP) 11.5 LowHigh
52 Week Price Range 93.1% 1 Year return Unavailable in chosen country	1.1 (LTP) 0.27.5 LowHigh

View full Share Price History

BioVie Inc Live Price Chart

Switch to TradingView

Fetching data ...

BioVie Inc Stock Analysis

BioVie Inc stock analysis with key metrics, changes, and trends.

BioVie Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Net Profit	$32.12 M	36.09%	positive	Annual Net Profit rose 36.09% in the last year to $32.12 M. Its sector's average net profit growth for the last fiscal year was -32.43%.
Price to Earning Ratio	-0.85	-	negative	Price to Earning Ratio is -0.85, which is negative.
Stock Price	$1.12	93.1%	positive	Stock Price rose 93.1% and outperformed its sector by 84.03% in the past year.
Quarterly Net profit	$7.11 M	15.34%	positive	Quarterly Net profit rose 15.34% YoY to $7.11 M. Its sector's average net profit growth YoY for the quarter was -47.3%.
Debt to Equity Ratio	0.39	-	positive	Debt to Equity Ratio of 0.39 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	-214.01 %	-214.01%	negative	Return on Equity(ROE) for the last financial year was -214.01%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	4.61 %	2.57%	positive	Mutual Fund Holding increased by 2.57% in the last quarter to 4.61.
Promoter Share Holding	7.89 %	0%	neutral	Promoter Share Holding stayed the same in the most recent quarter at 7.89%.
Interest Coverage Ratio	-10.1	-	negative	Interest Coverage Ratio is -10.1, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).
Institutional Holding	9.68 %	2.86%	positive	Institutional Holding increased by 2.86% in the last quarter to 9.68.

VIEW LESS

Loading data..

BioVie Inc - Company Profile

What does BioVie Inc do?

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

BioVie Inc Management structure

All Gross Remunerations are in USD

Mr. Cuong Viet Do

Director, President and Chief Executive Officer

777.08 K

2024

Gross Remuneration

Year

Dr. Joseph M. Palumbo, M.D.

Chief Medical Officer

669.58 K

2024

Gross Remuneration

Year

Ms. Joanne Wendy Kim

Chief Financial Officer, Treasurer and Corporate Secretary

339.25 K

2024

Gross Remuneration

Year

BioVie Inc Board of directors

All Gross Remunerations are in USD

Mr. Steve Gorlin

Independent Director

2025

Gross Remuneration

Year

BioVie Inc Live Share Price Today, Share Analysis and Chart

85.07% Fall from 52W High

BioVie Inc Key Metrics

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

BioVie Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

BioVie Inc Live Price Chart

BioVie Inc Stock Analysis

BioVie Inc stock analysis with key metrics, changes, and trends.

Annual Net Profit rose 36.09% in the last year to $32.12 M. Its sector's average net profit growth for the last fiscal year was -32.43%.

Price to Earning Ratio is -0.85, which is negative.

Stock Price rose 93.1% and outperformed its sector by 84.03% in the past year.

Quarterly Net profit rose 15.34% YoY to $7.11 M. Its sector's average net profit growth YoY for the quarter was -47.3%.

Debt to Equity Ratio of 0.39 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was -214.01%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding increased by 2.57% in the last quarter to 4.61.

Promoter Share Holding stayed the same in the most recent quarter at 7.89%.

Interest Coverage Ratio is -10.1, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding increased by 2.86% in the last quarter to 9.68.

BioVie Inc - Company Profile

What does BioVie Inc do?

BioVie Inc Management structure

Mr. Cuong Viet Do

Director, President and Chief Executive Officer

Dr. Joseph M. Palumbo, M.D.

Chief Medical Officer

Ms. Joanne Wendy Kim

Chief Financial Officer, Treasurer and Corporate Secretary

BioVie Inc Board of directors

Mr. Steve Gorlin

Independent Director

BioVie Inc FAQ

How is BioVie Inc today?

BioVie Inc today is trading in the red, and is down by -2.61% at 1.12.

How has BioVie Inc performed historically?

BioVie Inc is currently trading down -2.61% on an intraday basis. In the past week the stock rose 3.70%. stock has been down -41.05% in the past quarter and rose 93.10% in the past year. You can view this in the overview section.